FDA Advisers to Weigh New Gene Therapies for Sickle Cell Anemia

MONDAY, Oct. 30, 2023-- Patients with sickle cell disease may soon have two new treatments to try. On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a new gene therapy for the painful, inherited condition....